The Albumin Market size was estimated USD 0.9 billion in 2022 and is expected to reach USD 1.43 billion by 2030 at a CAGR of 6.0% during the forecast period of 2023-2030.

The Albumin Market is a rapidly growing sector in the healthcare industry, driven by the increasing demand for albumin-based therapies and diagnostic applications. Albumin, a protein found in blood plasma, plays a crucial role in maintaining osmotic pressure, transporting hormones and drugs, and regulating cell growth.

One of the key factors driving the growth of the albumin market is the rising prevalence of chronic diseases such as liver cirrhosis, kidney diseases, and cardiovascular disorders. These conditions often require albumin-based therapies to restore and maintain proper bodily functions. Additionally, the aging population worldwide is contributing to the increased demand for albumin products as elderly individuals are more prone to various health issues that necessitate albumin supplementation.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/3114

Moreover, advancements in biotechnology have led to the development of recombinant albumins that offer enhanced therapeutic properties compared to traditional human serum albumin (HSA). Recombinant albumins are produced through genetic engineering techniques and can be customized to suit specific therapeutic needs. This has opened up new possibilities for the medical field, as recombinant albumins can be tailored to target specific diseases and conditions. This personalized approach allows for more effective treatment options and improved patient outcomes. Additionally, the use of recombinant albumins reduces the risk of adverse reactions and infections that can occur with traditional albumin products derived from human donors. With ongoing research and development, the potential applications of recombinant albumins in various medical fields, such as regenerative medicine and drug delivery, continue to expand.

KEY MARKET SEGMENTS

By Type

·         Human Serum Albumin

·         Recombinant Albumin

·         Bovine Serum Albumin

By Application

·         Drug Delivery

·         Therapeutics

·         Culture Media Ingredient

·         Vaccine Ingredient

·         Others

Major Players Listed in the Report are as Follows:

Baxter International Inc., China Biologic Products, Inc, CSL Limited, Grifols, S.A., Merck KGaA, Novozymes, Octapharma AG, Takeda Pharmaceuticals Inc, Thermo Fisher Scientific, Ventria Bioscience and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)